-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Verve Therapeutics, Inc. quarterly General and Administrative Expense history and growth rate from 2019 to 2024.
- Verve Therapeutics, Inc. General and Administrative Expense for the quarter ending March 31, 2024 was $14.2M, a 12.8% increase year-over-year.
- Verve Therapeutics, Inc. General and Administrative Expense for the twelve months ending March 31, 2024 was $51.5M, a 20.9% increase year-over-year.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly Data (USD)